After trials at multiple NHS trusts, the government says immersive technologies have the potential to transform therapy and healthcare. And the interventions tested - using virtual-reality kits to treat pain and phobias, for example - could save the NHS £2m every year.
Overall, the VR industry is expected to reach a value of $1.2bn (£900m) globally by 2024. Projections estimate 6.1 million devices will have been sold by the end of 2021. But some still risks exist, including nausea and fatigue, if the technology was poorly designed.
More information: